The WG3 will be in charge of developing the Methodology and validation protocols of future urinary tract stents.

Milestones.

  1. The production of a validation protocol (design, control, guidance for medical devices) (M16).
  2. Tests via in-silico simulation, 3D-printing, Exvivo-Invivo assessment and Preclinical testing considerations (M24).

D3. Report on Comprehensive Methodology and Validation protocol on new stent designs, including scientific publications related to the WG3 of the Action (M24), with TS and STSM related to the WG3 of the Action (M24).

Leader: Sotir Stavridis
Vice-Leader: Niels-P. Buchholz


We are processing your form, please wait.

Update in urinary stents. Indications-Complications-Technology. Theory & Practice

26-27 November, Cáceres, Spain


Training school admission is free of charge and we very much hope that you are interested to participate. For registration to the training school, please fill in and submit the online form until 5th November 2018.

Participate! Learn More